Zoltan Arany1, Michael Neinast2. 1. Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, TRC 11-106 3400 Civic Blvd, Philadelphia, PA, 19104, USA. zarany@pennmedicine.upenn.edu. 2. Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, TRC 11-106 3400 Civic Blvd, Philadelphia, PA, 19104, USA.
Abstract
PURPOSE OF REVIEW: Elevations in circulating branched chain amino acids (BCAAs) have gained attention as potential contributors to the development of insulin resistance and diabetes. RECENT FINDINGS: Epidemiological evidence strongly supports this conclusion. Suppression of BCAA catabolism in adipose and hepatic tissues appears to be the primary drivers of plasma BCAA elevations. BCAA catabolism may be shunted to skeletal muscle, where it indirectly leads to FA accumulation and insulin resistance, via a number of proposed mechanisms. BCAAs have an important role in the development of IR, but our understanding of how plasma BCAA elevations occur, and how these elevations lead to insulin resistance, is still limited.
PURPOSE OF REVIEW: Elevations in circulating branched chain amino acids (BCAAs) have gained attention as potential contributors to the development of insulin resistance and diabetes. RECENT FINDINGS: Epidemiological evidence strongly supports this conclusion. Suppression of BCAA catabolism in adipose and hepatic tissues appears to be the primary drivers of plasma BCAA elevations. BCAA catabolism may be shunted to skeletal muscle, where it indirectly leads to FA accumulation and insulin resistance, via a number of proposed mechanisms. BCAAs have an important role in the development of IR, but our understanding of how plasma BCAA elevations occur, and how these elevations lead to insulin resistance, is still limited.
Authors: Yuvaraj Mahendran; Anna Jonsson; Christian T Have; Kristine H Allin; Daniel R Witte; Marit E Jørgensen; Niels Grarup; Oluf Pedersen; Tuomas O Kilpeläinen; Torben Hansen Journal: Diabetologia Date: 2017-02-10 Impact factor: 10.122
Authors: Helle Krogh Pedersen; Valborg Gudmundsdottir; Henrik Bjørn Nielsen; Tuulia Hyotylainen; Trine Nielsen; Benjamin A H Jensen; Kristoffer Forslund; Falk Hildebrand; Edi Prifti; Gwen Falony; Emmanuelle Le Chatelier; Florence Levenez; Joel Doré; Ismo Mattila; Damian R Plichta; Päivi Pöhö; Lars I Hellgren; Manimozhiyan Arumugam; Shinichi Sunagawa; Sara Vieira-Silva; Torben Jørgensen; Jacob Bak Holm; Kajetan Trošt; Karsten Kristiansen; Susanne Brix; Jeroen Raes; Jun Wang; Torben Hansen; Peer Bork; Søren Brunak; Matej Oresic; S Dusko Ehrlich; Oluf Pedersen Journal: Nature Date: 2016-07-13 Impact factor: 49.962
Authors: Kinyui Alice Lo; Adam Labadorf; Norman J Kennedy; Myoung Sook Han; Yoon Sing Yap; Bryan Matthews; Xiaofeng Xin; Lei Sun; Roger J Davis; Harvey F Lodish; Ernest Fraenkel Journal: Cell Rep Date: 2013-10-03 Impact factor: 9.423
Authors: Geoffrey A Walford; Yong Ma; Clary Clish; Jose C Florez; Thomas J Wang; Robert E Gerszten Journal: Diabetes Date: 2016-02-09 Impact factor: 9.461
Authors: Peter Würtz; Pasi Soininen; Antti J Kangas; Tapani Rönnemaa; Terho Lehtimäki; Mika Kähönen; Jorma S Viikari; Olli T Raitakari; Mika Ala-Korpela Journal: Diabetes Care Date: 2012-11-05 Impact factor: 19.112
Authors: Kirsi H Pietiläinen; Jussi Naukkarinen; Aila Rissanen; Juha Saharinen; Pekka Ellonen; Heli Keränen; Anu Suomalainen; Alexandra Götz; Tapani Suortti; Hannele Yki-Järvinen; Matej Oresic; Jaakko Kaprio; Leena Peltonen Journal: PLoS Med Date: 2008-03-11 Impact factor: 11.069
Authors: Fenglei Wang; Megu Y Baden; Marta Guasch-Ferré; Clemens Wittenbecher; Jun Li; Yanping Li; Yi Wan; Shilpa N Bhupathiraju; Deirdre K Tobias; Clary B Clish; Lorelei A Mucci; A Heather Eliassen; Karen H Costenbader; Elizabeth W Karlson; Alberto Ascherio; Eric B Rimm; JoAnn E Manson; Liming Liang; Frank B Hu Journal: Diabetologia Date: 2022-04-08 Impact factor: 10.122